Environmental Triggering of Type 1 Diabetes Autoimmunity

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Aug 8

PMID 35937815

Authors

Pamela Houeiss

Sandrine Luce

Christian Boitard

Affiliations

Soon will be listed here.

Abstract

Type 1 diabetes (T1D) is a chronic autoimmune disease in which pancreatic islet β cells are destroyed by immune cells, ultimately leading to overt diabetes. The progressive increase in T1D incidence over the years points to the role of environmental factors in triggering or accelerating the disease process which develops on a highly multigenic susceptibility background. Evidence that environmental factors induce T1D has mostly been obtained in animal models. In the human, associations between viruses, dietary habits or changes in the microbiota and the development of islet cell autoantibodies or overt diabetes have been reported. So far, prediction of T1D development is mostly based on autoantibody detection. Future work should focus on identifying a causality between the different environmental risk factors and T1D development to improve prediction scores. This should allow developing preventive strategies to limit the T1D burden in the future.

Citing Articles

Autoimmune Type 1 Diabetes: An Early Approach Appraisal for Spain by the AGORA Diabetes Collaborative Group.

Gomez-Peralta F, Pines-Corrales P, Santos E, Cuesta M, Gonzalez-Albarran O, Azriel S J Clin Med. 2025; 14(2).

PMID: 39860426 PMC: 11766439. DOI: 10.3390/jcm14020418.

How do immune cells shape type 1 diabetes? Insights from Mendelian randomization.

Yu Y, Yang X, Deng J, Wu J, Bai S, Yu R Front Endocrinol (Lausanne). 2025; 15():1402956.

PMID: 39777226 PMC: 11703746. DOI: 10.3389/fendo.2024.1402956.

Celiac disease autoimmunity among Nigerian children and adolescents with type 1 diabetes mellitus.

Senbanjo I, Abolurin O, Adekoya A, Akinola I, Anyabolu C, Adeniyi O BMC Gastroenterol. 2024; 24(1):400.

PMID: 39528999 PMC: 11552209. DOI: 10.1186/s12876-024-03491-6.

Advances in Type 1 Diabetes Mellitus Management in Children.

Bahal M, Pande V, Dua J, Mane S Cureus. 2024; 16(8):e67377.

PMID: 39310514 PMC: 11416143. DOI: 10.7759/cureus.67377.

Investigating the Interplay: Periodontal Disease and Type 1 Diabetes Mellitus-A Comprehensive Review of Clinical Studies.

Vlachou S, Loume A, Giannopoulou C, Papathanasiou E, Zekeridou A Int J Mol Sci. 2024; 25(13).

PMID: 39000406 PMC: 11242877. DOI: 10.3390/ijms25137299.

References

Cinek O, Stene L, Kramna L, Tapia G, Oikarinen S, Witso E . Enterovirus RNA in longitudinal blood samples and risk of islet autoimmunity in children with a high genetic risk of type 1 diabetes: the MIDIA study. Diabetologia. 2014; 57(10):2193-200. DOI: 10.1007/s00125-014-3327-4. View

Pathiraja V, Kuehlich J, Campbell P, Krishnamurthy B, Loudovaris T, Coates P . Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes. Diabetes. 2014; 64(1):172-82. DOI: 10.2337/db14-0858. View

Colli M, Szymczak F, Eizirik D . Molecular Footprints of the Immune Assault on Pancreatic Beta Cells in Type 1 Diabetes. Front Endocrinol (Lausanne). 2020; 11:568446. PMC: 7522353. DOI: 10.3389/fendo.2020.568446. View

Patel K, Oram R, Flanagan S, De Franco E, Colclough K, Shepherd M . Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes. Diabetes. 2016; 65(7):2094-2099. PMC: 4920219. DOI: 10.2337/db15-1690. View

Marre M, Piganelli J . Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes. Front Endocrinol (Lausanne). 2017; 8:262. PMC: 5626851. DOI: 10.3389/fendo.2017.00262. View

Scott F, Rowsell P, Wang G, Burghardt K, Kolb H, Flohe S . Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes. Diabetes. 2002; 51(1):73-8. DOI: 10.2337/diabetes.51.1.73. View

Steck A, Rewers M . Genetics of type 1 diabetes. Clin Chem. 2011; 57(2):176-85. PMC: 4874193. DOI: 10.1373/clinchem.2010.148221. View

Ahmed R, Omidian Z, Donner T, Hamad A . Hiding in plain sight: time to unlock autoimmune clues in human CD5+ B cells by using nextgen technology. Discov Med. 2018; 26(142):79-83. PMC: 7879960. View

Yang C, Shin D, Kim K, Lee Z, Lee C, Park S . NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression. J Immunol. 2009; 182(6):3696-705. DOI: 10.4049/jimmunol.0802217. View

10.

Davis-Richardson A, Triplett E . A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia. 2015; 58(7):1386-93. PMC: 4473028. DOI: 10.1007/s00125-015-3614-8. View

11.

Burg A, Tse H . Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes. Antioxid Redox Signal. 2017; 29(14):1373-1398. PMC: 6166692. DOI: 10.1089/ars.2017.7243. View

12.

Bansal A, Pinney S . DNA methylation and its role in the pathogenesis of diabetes. Pediatr Diabetes. 2017; 18(3):167-177. PMC: 5394941. DOI: 10.1111/pedi.12521. View

13.

Falcone M, Fousteri G . Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes. Front Endocrinol (Lausanne). 2020; 11:569. PMC: 7466754. DOI: 10.3389/fendo.2020.00569. View

14.

Hagopian W, Erlich H, Lernmark A, Rewers M, Ziegler A, Simell O . The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes. 2011; 12(8):733-43. PMC: 3315186. DOI: 10.1111/j.1399-5448.2011.00774.x. View

15.

Chakir H, Lefebvre D, Wang H, Caraher E, Scott F . Wheat protein-induced proinflammatory T helper 1 bias in mesenteric lymph nodes of young diabetes-prone rats. Diabetologia. 2005; 48(8):1576-84. DOI: 10.1007/s00125-005-1842-z. View

16.

Hu X, Deutsch A, Lenz T, Onengut-Gumuscu S, Han B, Chen W . Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nat Genet. 2015; 47(8):898-905. PMC: 4930791. DOI: 10.1038/ng.3353. View

17.

Brugman S, Klatter F, Visser J, Wildeboer-Veloo A, Harmsen H, Rozing J . Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?. Diabetologia. 2006; 49(9):2105-8. DOI: 10.1007/s00125-006-0334-0. View

18.

Ivanov I, de Llanos Frutos R, Manel N, Yoshinaga K, Rifkin D, Sartor R . Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008; 4(4):337-49. PMC: 2597589. DOI: 10.1016/j.chom.2008.09.009. View

19.

Yang C, Kim J, Lee S, Hwang J, Lee C, Lee M . TLR3-triggered reactive oxygen species contribute to inflammatory responses by activating signal transducer and activator of transcription-1. J Immunol. 2013; 190(12):6368-77. DOI: 10.4049/jimmunol.1202574. View

20.

Livanos A, Greiner T, Vangay P, Pathmasiri W, Stewart D, McRitchie S . Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. Nat Microbiol. 2016; 1(11):16140. PMC: 5808443. DOI: 10.1038/nmicrobiol.2016.140. View